scispace - formally typeset
J

Jeffrey M. Tessier

Researcher at University of Texas Southwestern Medical Center

Publications -  36
Citations -  687

Jeffrey M. Tessier is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Medicine & Retrospective cohort study. The author has an hindex of 8, co-authored 28 publications receiving 482 citations. Previous affiliations of Jeffrey M. Tessier include Baylor University & John Peter Smith Hospital.

Papers
More filters
Journal ArticleDOI

The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection.

TL;DR: This guideline summarizes the current recommendations developed by the SIS task force on the treatment of patients who have IAI regarding risk assessment in individual patients; source control; the timing, selection, and duration of antimicrobial therapy; and suggested approaches to patients who fail initial therapy.
Journal ArticleDOI

Antimicrobial Stewardship: A Call to Action for Surgeons.

TL;DR: Surgeons must be aware that judicious antibiotic utilization is an integral part of any stewardship program and necessary to maximize clinical cure and minimize emergence of antimicrobial resistance, and play a major role in these collaborations.
Journal ArticleDOI

The Global Alliance for Infections in Surgery: Defining a model for antimicrobial stewardship-results from an international cross-sectional survey

Massimo Sartelli, +166 more
TL;DR: The survey showed a heterogeneous organization of ASPs worldwide, demonstrating the necessity of a multidisciplinary and collaborative approach in the battle against antimicrobial resistance in surgical infections, and the importance of educational efforts towards this goal.
Journal ArticleDOI

Contributions of histamine, prostanoids, and neurokinins to edema elicited by edema toxin from Bacillus anthracis

TL;DR: The results indicate that ET, acting indirectly or directly on a target yet to be identified, stimulates the production/release of multiple inflammatory mediators, specifically neurokinins, prostanoids, and histamine, which increase vascular permeability and interventions directed at these mediators may benefit hosts infected with B. anthracis.